The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the ...

After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet ...

An independent playing philosophy, full-time coaches and the long-term objective of the first-team squad: With a new ...

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.

There was a ceiling,” he said. "I saw the chance to do something different—something I could shape from scratch.” ...

Together, Bayer and Corteva now control approximately 70% of the corn and soybean seed market in the U.S., a significant increase from around 40% two decades ago, according to USDA data.

Bayer Leverkusen open door for £23m Adli exit as Sunderland eye move after Granit Xhaka deal near Bayer Leverkusen sporting director Simon Rolfes has admitted that Amine Adli’s future remains “open” ...